Oak HC/FT is a venture and growth equity investment firm that focuses on healthcare information services and financial service technology.
Business Model: B2B
Revenue: $5.8M
Employees: 51-200
Address: 3 Pickwick Plz
City: Greenwich
State: CT
Zip: 06830
Country: US
Oak HC/FT is a venture and growth equity investment firm that focuses on healthcare information services and financial service technology. The firm focuses on driving transformation in these industries by providing entrepreneurs and companies with strategic counsel, board-level participation, and access to our extensive network of industry leaders. Oak HC/FT partners are peerless in delivering returns for investors and growing innovative businesses. Over the past decade, the partners at Oak HC/FT have had 20 realizations with 6 companies achieving valuations in excess of $1 billion. Oak HC/FT is led by the Healthcare and FinTech team of Oak Investment Partners as part of Oak’s strategy to develop sector-specific funds and continue its legacy of building best-in-class businesses.
Contact Phone:
+12037171350
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2023 | Panorays | Series C | - |
12/2021 | Reveleer | Venture Round | 0 |
9/2021 | TurningPoint Healthcare Solutions | Private Equity Round | - |
8/2018 | Pagaya | Series B | 0 |
4/2019 | Pagaya | Series C | 25M |
11/2014 | FastPay | Venture Round | 15M |
3/2016 | Trōv | Series C | 0 |
11/2021 | Infusion for Health | Venture Round | 0 |
8/2019 | Sema4 | Series B | 120M |
11/2021 | ZenBusiness | Series C | 200M |
6/2021 | Syllable | Series B | 28M |
5/2015 | Feedzai | Series B | 17.5M |
2/2020 | Wayspring | Series C | 15M |
7/2020 | August Bioservices | Venture Round | - |
10/2016 | Wayspring | Series B | 16.5M |
9/2021 | Wayspring | Series D | 0 |
5/2020 | OncoHealth | Series C | 28M |
6/2020 | Urjanet | Series D | 14.7M |
9/2022 | Ethic | Series C | 50M |
6/2015 | Aspire Health | Series C | 15M |
3/2019 | Unite Us | Series B | 0 |
7/2022 | Everside Health | Venture Round | 0 |
9/2020 | Truepill | Series C | 75M |
3/2022 | Rialtic | Series A | 0 |
6/2020 | Pagaya | Series D | 0 |
11/2018 | OncoHealth | Series B | 21M |
7/2015 | Core Informatics | Series B | 17.5M |
1/2020 | Komodo Health | Series C | 50M |
3/2017 | Urjanet | Series C | 0 |
10/2014 | Limeade | Series C | 25M |
5/2021 | August Bioservices | Series A | 23.6M |
1/2018 | NextCapital | Series C | 0 |
8/2020 | Ocrolus | Series B | 13.5M |
9/2018 | Maven Clinic | Series B | 27M |
12/2021 | Quartet Health | Corporate Round | 60M |
5/2021 | Noom | Series F | 540M |
9/2018 | Cricket Health | Series A | 0 |
10/2020 | Cerebral | Series A | 35M |
11/2022 | Maven Clinic | Series E | 90M |
10/2019 | Rapyd | Series C | 100M |
8/2020 | Brightline | Series A | 0 |
11/2022 | DispatchHealth | Series E | 330M |
3/2022 | Osso VR | Series C | 0 |
7/2018 | Groundspeed Analytics | Series B | 30M |
1/2021 | Groundspeed Analytics | Series C | - |
10/2016 | LDI | Private Equity Round | - |
1/2021 | Rapyd | Series D | 300M |
8/2018 | Everside Health | Private Equity Round | 165M |
10/2021 | Modern Age | Series A | 0 |
4/2022 | IMMO Capital | Series B | 0 |
3/2021 | DispatchHealth | Series D | 0 |
12/2022 | August Bioservices | Series B | 0 |
7/2022 | Everside Health | Private Equity Round | 164M |
8/2021 | Cart.com | Series B | 0 |
11/2020 | WithMe Health | Series B | 25M |
6/2018 | OODA Health | Series A | 0 |
9/2021 | Highnote | Series A | 0 |
1/2020 | CareBridge | Venture Round | 40M |
9/2021 | Sendoso | Series C | 0 |
4/2016 | Quartet Health | Series B | 40M |
6/2021 | Brightline | Series B | 0 |
10/2017 | Devoted Health | Series A | 62M |
1/2018 | Quartet Health | Series C | 45M |
6/2019 | Quartet Health | Series D | 0 |
10/2015 | Digital Currency Group | Seed Round | - |
4/2021 | Paxos | Series D | 0 |
12/2017 | Kasisto | Series B | 17M |
9/2019 | Kasisto | Series B | 15M |
12/2019 | Inscripta | Series D | 125M |
7/2022 | Aptos | Series A | 0 |
3/2022 | Brightline | Series C | 0 |
3/2022 | Mendel.ai | Series B | 40M |
3/2021 | Ethic | Series B | 29M |
10/2020 | Highnote | Seed Round | 11.5M |
11/2019 | AU10TIX | Venture Round | 20M |
7/2018 | Olive | Series D | 32.8M |
11/2020 | WithMe Health | Series B | 20M |
1/2016 | CareGuardian | Series B | 27.5M |
6/2021 | Cerebral | Series B | 127M |
11/2018 | Vesta Healthcare | Series A | 10M |
4/2021 | Vesta Healthcare | Venture Round | 65M |
1/2018 | CLARA Analytics | Series A | 11.5M |
2/2020 | Maven Clinic | Series C | 52M |
8/2021 | Maven Clinic | Series D | 110M |
9/2021 | Ocrolus | Series C | 80M |
8/2021 | Cricket Health | Series B | 0 |
6/2021 | AllyAlign Health | Venture Round | - |
11/2021 | Aplazo | Series A | 27M |
12/2019 | Panorays | Series A | 15M |
7/2018 | Therapy Brands | Private Equity Round | - |
4/2021 | Clearco | Debt Financing | 248.2M |
2/2016 | Maestro Health | Series A | 53M |
10/2020 | Rialtic | Series A | 15M |
6/2016 | US HealthVest | Series B | 50M |
3/2015 | Quartet Health | Series A | 7M |
10/2015 | Insureon | Series B | 0 |
9/2020 | NextCapital | Series D | 30M |
11/2021 | EasySend | Series B | 50.5M |
6/2022 | CareBridge | Venture Round | 0 |
10/2019 | Namogoo | Series C | 40M |
2/2020 | Sendoso | Series B | 40M |
3/2020 | Olive | Series E | 52M |
4/2021 | Firefly Health | Series B | 40M |
9/2019 | Firefly Health | Series A | 10.2M |
8/2019 | Wisetack | Series A | 15M |
11/2021 | Justt | Series B | 50M |
9/2018 | Notable | Series A | 13.5M |
11/2021 | Notable | Series B | 100M |
6/2019 | Ocrolus | Series B | 24M |
3/2021 | Advise Health | Series A | 100M |
2/2021 | Circulo | Series A | 50M |
9/2019 | VillageMD | Series B | 100M |
5/2021 | Groups Recover Together | Series C | 60M |
9/2022 | MPCH Labs | Series A | 40M |
10/2016 | Aspire Health | Series D | 32M |
5/2019 | Galileo | Series A | - |
6/2020 | DispatchHealth | Series C | 135.8M |
3/2022 | 99 Minutos | Series C | 0 |
12/2019 | Brightline | Seed Round | 5M |
7/2021 | VEDA Data Solutions | Series B | 45M |
4/2017 | Trōv | Series D | 0 |
9/2020 | Olive | Series F | 106M |
10/2015 | Poynt | Series B | 28M |
9/2015 | VillageMD | Series A | 36M |
7/2020 | Sema4 | Series C | 121M |
2/2022 | Syllable | Series C | 0 |
8/2018 | Everside Health | Growth | 165M |
11/2021 | U.S. Medical Management | Venture Round | - |
5/2020 | CLARA Analytics | Series B | 0 |
4/2021 | Clearco | Series C | 99.1M |
2/2019 | Kryon | Series C | 40M |
1/2020 | Vesta Healthcare | Series A | 30M |
10/2018 | Devoted Health | Series B | 0 |
9/2021 | Panorays | Series B | 0 |
7/2022 | Everside Health | Venture Round | 0 |
7/2022 | Aptos | Series A | 0 |
6/2022 | CareBridge | Venture Round | 0 |
4/2022 | IMMO Capital | Series B | 0 |
3/2022 | Brightline | Series C | 0 |
3/2022 | Mendel.ai | Series B | 0 |
3/2022 | Osso VR | Series C | 0 |
3/2022 | Rialtic | Series A | 0 |
3/2022 | 99 Minutos | Series C | 0 |
2/2022 | Syllable | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|